Overview
What is The Adenoid Cystic Carcinoma Research Foundation?
The Adenoid Cystic Carcinoma Research Foundation, headquartered in Needham, Massachusetts, is a dedicated nonprofit organization with a mission to advance research into the treatment and potential cure for Adenoid Cystic Carcinoma (ACC). Their primary focus is on supporting and coordinating studies that show promise for clinical benefits for ACC patients. This involves drug discovery, drug development, preclinical drug screening, and correlate studies, all of which are crucial in initiating and optimally conducting clinical trials. By doing so, the foundation aims to accelerate the development of improved therapies and ultimately, a cure for this disease. The organization currently employs a team of two individuals in its pursuit of this goal.
Official website here: www.accrf.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 96% (Four-Star out of Four Stars)
The Adenoid Cystic Carcinoma Research Foundation has earned an impressive Four-Star rating from Charity Navigator, indicating a high level of accountability and financial health. The overall score is derived from a strong performance in the Accountability & Finance beacon, reflecting the organization’s commitment to transparency and effective management of resources.
One of the notable strengths of the foundation is its governance structure, with 77% of board members being independent. This independence is crucial for maintaining objectivity in decision-making. Furthermore, the foundation has demonstrated strong financial oversight practices, including a robust audit and oversight committee, and it has not reported any material diversion of assets, which enhances its credibility.
Despite its strengths, the data does not indicate any specific limitations. Instead, the foundation's high program expense ratio of 93.44% suggests that a significant portion of its funds is directed toward its mission-related programs, thereby maximizing the impact of its initiatives against adenoid cystic carcinoma. Overall, the foundation stands out as a responsible and effective organization in its field.
This AI summary has been generated from information found on Charity Navigator.
Is The Adenoid Cystic Carcinoma Research Foundation legitimate?
The Adenoid Cystic Carcinoma Research Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Adenoid Cystic Carcinoma Research Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $150,001
Professional Fundraising Fees: $0
Other Salaries and Wages: $213,730
For more financial information, click here
Official website here: www.accrf.org
What is the mission statement of The Adenoid Cystic Carcinoma Research Foundation?
The Adenoid Cystic Carcinoma Research Foundation (ACCRF) is committed to supporting research aimed at accelerating the development of improved treatments and potentially a cure for Adenoid Cystic Carcinoma. The organization's mission is to facilitate studies that could lead to clinical benefits for patients battling this disease. Crucial aspects of this research include drug discovery, drug development, preclinical drug screening, and correlative studies, which are essential for the successful initiation and optimal conduct of clinical trials. By doing so, the ACCRF aims to contribute significantly to the fight against Adenoid Cystic Carcinoma.
Official website here: www.accrf.org
What is the revenue of The Adenoid Cystic Carcinoma Research Foundation?
The Adenoid Cystic Carcinoma Research Foundation's revenue in 2023 was $1,893,545.
Official website here: www.accrf.org
Who are the executives of The Adenoid Cystic Carcinoma Research Foundation and what are their salaries?
The average compensation at The Adenoid Cystic Carcinoma Research Foundation during 2023 was $121,244. There are 3 employees and 1 volunteer at The Adenoid Cystic Carcinoma Research Foundation.
Here are 10 key members and their salaries:
- Compensation: $150,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $135,000
- Related: $0
- Other: $0
Official website here: www.accrf.org
Where can I find the form 990 for The Adenoid Cystic Carcinoma Research Foundation?
The Adenoid Cystic Carcinoma Research Foundation's most recent form 990 was submitted in 2023 and can be accessed here.
Official website here: www.accrf.org
Learn more at the official website: www.accrf.org
Mission Statement of The Adenoid Cystic Carcinoma Research Foundation
The Adenoid Cystic Carcinoma Research Foundation (ACCRF) is committed to advancing research into the treatment and potential cure for Adenoid Cystic Carcinoma. Their mission is to accelerate the development of improved therapies for this disease by supporting and coordinating studies that are most likely to yield clinical benefits for patients. This involves critical work in drug discovery, drug development, preclinical drug screening, and correlative studies, all of which are essential for the successful initiation and optimal conduct of clinical trials. In essence, the ACCRF is dedicated to driving progress in the fight against Adenoid Cystic Carcinoma, aiming to ultimately eradicate this disease and improve the lives of those affected.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Adenoid Cystic Carcinoma Research Foundation (ACCRF) plays a critical role in advancing research aimed at improving therapies and finding a cure for adenoid cystic carcinoma (ACC). By supporting and coordinating efforts in drug discovery, development, and preclinical drug screening, ACCRF focuses on translating research into clinical benefits for patients. This targeted approach ensures that new treatments are not only developed but also tested through rigorous correlation studies. The foundation's commitment to research accelerates the progression toward effective therapies, ultimately enhancing patient outcomes and advancing the understanding of this rare cancer. Their work facilitates clinical trials that are vital for bringing innovative treatments to those affected by ACC, making a significant impact on the medical landscape for patients and researchers alike.
This information is meant to be a general summary of The Adenoid Cystic Carcinoma Research Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Investment Income: $60,268
- Program Service Revenue: $1,054,422
- Gross Receipts: $1,919,242
Assets and Liabilities:
- Total Assets: $2,659,707
- Total Liabilities: $136,888
- Net Assets: $2,522,819
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
RESEARCH STUDIES
Revenue
$1,054,422
Organization Details
Founding Year
2005
Principal Officer
Jeffrey A Kaufman
Website
www.accrf.orgNTEE Category
Code: H12 - Medical research
If you are a representative of The Adenoid Cystic Carcinoma Research Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.